IP Library › Assignment 057597/0774
Patent Assignment
Reel/Frame 057597/0774

Assignment of Assignor's Interest

Recorded: 2021-09-15 Pages: 5
Assignor
SYNBLIA THERAPEUTICS, INC.
Executed: 2021-08-20
Assignee
CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
NO. 2, FLOOR 2, RONGYAO BUILDING, 5 KEYUAN SOUTH ROAD, CHENGDU HI-TECH INDUSTRIAL DEVELOPMENT ZONE, SICHUAN PROVINCE, CHINA
Covered Properties (5)
SHP2 Inhibitors and Uses Thereof
SHP2 Inhibitors and Uses Thereof
Application: 16/356,360 →
Publication: US 2019/0290649
SHP2 Inhibitors and Uses Thereof
Application: 62/646,107 →
SHP2 Inhibitors and Uses Thereof
Application: 62/904,377 →
SHP2 Inhibitors and Uses Thereof
Application: 62/904,493 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 21, 2018
From: XIE, YINONG; BABISS, LEE E.
To: SYNBLIA THERAPEUTICS, INC.
Reel/Frame 045304/0697 →
Assignment of Assignor's Interest Apr 18, 2019
From: XIE, YINONG; BABISS, LEE E.
To: SYNBLIA THERAPEUTICS, INC.
Reel/Frame 048932/0755 →
Assignment of Assignor's Interest Sep 27, 2019
From: XIE, YINONG; BABISS, LEE E.
To: SYNBLIA THERAPEUTICS, INC.
Reel/Frame 050527/0124 →
Assignment of Assignor's Interest Sep 27, 2019
From: XIE, YINONG; BABISS, LEE E.
To: SYNBLIA THERAPEUTICS, INC.
Reel/Frame 050527/0277 →
Assignment of Assignor's Interest Oct 5, 2020
From: XIE, YINONG; BABISS, LEE E.
To: SYNBLIA THERAPEUTICS, INC.
Reel/Frame 053973/0531 →
Assignment of Assignor's Interest Sep 29, 2021
From: CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
To: SUZHOU PUHE BIOPHARMA CO., LTD.
Reel/Frame 057648/0120 →
Corrective Assignment to Correct the Application Number of Pct/US19/22717 in the Appendix I , Which Erroneously Inputted as Pct/US16/22717 Previously Recorded at Reel: 057597 Frame: 0774. Assignor(S) Hereby Confirms the Assignment. Oct 15, 2021
From: SYNBLIA THERAPEUTICS, INC.
To: CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
Reel/Frame 057818/0643 →
Corrective Assignment to Correct the Application Number of Pct/US19/22717 in the Appendix I, Which Erroneously Inputted as Pct/US16/22717 Previously Recorded at Reel: 057648 Frame: 0120. Assignor(S) Hereby Confirms the Assignment. Oct 15, 2021
From: CHENGDU SYNBLIC THERAPEUTICS INC., LTD.
To: SUZHOU PUHE BIOPHARMA CO., LTD.
Reel/Frame 057820/0077 →